Imunon, Inc. (IMNN)
NASDAQ: IMNN · Real-Time Price · USD
0.980
+0.030 (3.15%)
At close: Nov 4, 2024, 4:00 PM
0.955
-0.025 (-2.54%)
After-hours: Nov 4, 2024, 7:42 PM EST
Imunon Employees
Imunon had 33 employees as of December 31, 2023. The number of employees increased by 2 or 6.45% compared to the previous year.
Employees
33
Change (1Y)
2
Growth (1Y)
6.45%
Revenue / Employee
n/a
Profits / Employee
-$547,948
Market Cap
14.11M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Psychemedics | 116 |
Aspira Women's Health | 64 |
Evaxion Biotech | 49 |
Apollomics | 45 |
Sol-Gel Technologies | 36 |
IN8bio | 31 |
QT Imaging Holdings | 14 |
COSCIENS Biopharma | 12 |
IMNN News
- 4 days ago - IMUNON to Hold Third Quarter 2024 Financial Results and Business Update Conference Call on Thursday, November 7, 2024 - GlobeNewsWire
- 5 days ago - IMUNON to Present Phase 2 Data of IMNN-001 in Treatment of Newly Diagnosed Ovarian Cancer at SITC 39th Annual Meeting - GlobeNewsWire
- 4 weeks ago - IMUNON Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - UPDATE - IMUNON's Ovarian Cancer R&D Day to Feature Presentations from IMNN-001 Clinical Study Investigators, Immunology and Biostatistics Experts, and Executive Management - GlobeNewsWire
- 2 months ago - IMUNON to Host R&D Day on September 18th - GlobeNewsWire
- 2 months ago - Imunon, Inc. (IMNN) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - IMUNON Reports Second Quarter 2024 Financial Results and Provides a Business Update - GlobeNewsWire
- 3 months ago - IMUNON to Hold Second Quarter 2024 Financial Results and Business Update Conference Call on Wednesday, August 14, 2024 - GlobeNewsWire